Dishman Carbogen Amcis Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

The new solar power plant, has installed capacity of 1,200 kWp, comprises a total of 2,448 photovoltaic modules installed on an area of approximately 6,200 square meters of the company?s premises. This makes the plant one of the most efficient conventional ground-mounted systems in the Swiss Mittelland and brings its efficiency close to that of vertical alpine installations. Ground-mounted photovoltaic systems remain rare in Switzerland.

The project was carried out in collaboration with the company?s energy and infrastructure partners IWB (Industrielle Werke Basel) and its subsidiary Planeco, which were responsible for the planning and implementation of the facility.

Stephan Fritschi, chief executive officer of CARBOGEN AMCIS, said, ?With the commissioning of this photovoltaic system, we are making a targeted investment in a sustainable and future-oriented energy supply for our site. The project is an important milestone on our path to consistently implementing our environmental goals,?

Dishman Carbogen Amcis is a global outsourcing partner for the pharmaceutical industry, offering a portfolio of development, scale-up and manufacturing services. It provides a range of development and manufacturing solutions at locations in Europe, China and in India.

On consolidated basis, net profit declined 49.55% to Rs 21.74 crore in Q4 FY26, compared with Rs 43.09 crore in Q4 FY25. Revenue from operations jumped 18.85% YoY to Rs 851.40 crore in Q4 FY26.

Powered by Capital Market - Live News

Dishman Carbogen Amcis announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 19 June 2026.

Net profit of Dishman Carbogen Amcis declined 49.55% to Rs 21.74 crore in the quarter ended March 2026 as against Rs 43.09 crore during the previous quarter ended March 2025. Sales rose 18.85% to Rs 851.40 crore in the quarter ended March 2026 as against Rs 716.34 crore during the previous quarter ended March 2025.

For the full year,net profit rose 2907.72% to Rs 97.45 crore in the year ended March 2026 as against Rs 3.24 crore during the previous year ended March 2025. Sales rose 8.13% to Rs 2931.90 crore in the year ended March 2026 as against Rs 2711.50 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 19 May 2026.